ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,313.50
13.50 (1.04%)
Last Updated: 11:24:29
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  13.50 1.04% 1,313.50 1,313.00 1,314.00 1,313.50 1,300.00 1,300.00 827,486 11:24:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.04 53.89B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,300p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £53.89 billion. Gsk has a price to earnings ratio (PE ratio) of 11.04.

Gsk Share Discussion Threads

Showing 33526 to 33548 of 34050 messages
Chat Pages: Latest  1350  1349  1348  1347  1346  1345  1344  1343  1342  1341  1340  1339  Older
DateSubjectAuthorDiscuss
16/8/2024
10:20
The rising pound and a drop in the fuse is not helping GSK either.
abdullla
16/8/2024
09:49
GSK's Florida state court win is a positive twist in its Zantac litigation saga but concerns continue to cloud the business, AJ Bell Investment director Russ Mould says in a market comment. "The Zantac cloud is overshadowing the progress CEO Emma Walmsley has made in turning around the business and, notwithstanding the good news from Florida, this might continue to prove the case for some time to come," he says. The British pharma giant's continuing legal battle over links between Zantac and cancer remains an issue for the business due to its high case volume, the analyst says. GSK's hope that a similar case dismissal in late 2022 would mark the beginning of the end hasn't materialized yet, he says. The Florida ruling contrasts a Delaware court decision earlier this year that weighs more significantly on GSK, given it accounts for the majority of outstanding cases, Mould says.
dplewis1
16/8/2024
09:14
"precedence", abdullla - a good point, though
tradermichael
16/8/2024
07:21
The remaining cases ought to be dismissed under the laws of presidence
abdullla
16/8/2024
07:13
Give it time, there are a lot of court cases pending yet, but as the wins mount up we should gain traction and hopefully recover towards 1800 again..

Happy to hold and build HLN too, another keep for life share as their debt comes off and dividends ramp up.. :o)

laurence llewelyn binliner
16/8/2024
07:08
So predictable these MM,s. You could not make it up.
garycook
16/8/2024
07:07
Bizarre how this share reacts to news
spoole5
16/8/2024
07:05
It feels like ex dividend was today
abdullla
16/8/2024
07:05
Love the market reaction. Zantac is blamed for the laggard share price here all the time but any positive news on that front and the opening bell is always red!
theoriginalwonderstuff
16/8/2024
07:01
Down a tad at the open.
mister md
16/8/2024
06:52
Good news for Gsk. Should open at 1700.
Let's see how market reacts.

hjs
16/8/2024
06:46
Interesting choice of words in the RNS...Court's ruling is consistent with scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of *ANY* cancer
theoriginalwonderstuff
16/8/2024
06:19
As these Zantac court case wins stack up it adds more and more weight to the appeals underway in Delaware..We soon recovered most of the XD drop too..Onward and upward, see if we can recover to 1800 again..
laurence llewelyn binliner
16/8/2024
06:11
I hope we're in for a very good opening this morning!
theoriginalwonderstuff
16/8/2024
06:03
hTTps://www.londonstockexchange.com/news-article/GSK/statement-zantac-ranitidine-litigation/16621656
dplewis1
15/8/2024
11:24
Yup, that's what I'll probably do
dope007
15/8/2024
11:23
Averaging up?
tradermichael
15/8/2024
07:53
Was hoping for a larger drop to add one final tranche but never mind. My average in price is 1510p over the last couple of weeks
dope007
15/8/2024
07:31
Great open bearing in mind ex div
panache1
14/8/2024
18:05
Minus 15 pence on the open, but GSK should recover most of it by the closing bell.. :o)
laurence llewelyn binliner
14/8/2024
11:08
Not always does a share price drop ('big' or otherwise) on x-div day. Even if it does, it more often regains the amount the same day or soon after.
tradermichael
14/8/2024
11:04
So big drop tomorrow then .
abdullla
14/8/2024
07:45
x-div tomorrow .... ;0)
tradermichael
Chat Pages: Latest  1350  1349  1348  1347  1346  1345  1344  1343  1342  1341  1340  1339  Older

Your Recent History

Delayed Upgrade Clock